Aadi Bioscience, Inc. — Form D

Aadi Bioscience, Inc. of MORRISTOWN, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-10. The offering totals $82.5M, of which $82.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (31)

Showing 25 of 31 people.

NameRoleLocation
Karin HenebergerDirectorPacific Palisades, CA
Mohammad HirmandDirectorSan Diego, CA
Neil DesaiDirectorRye, NY
Neil DesaiExecutive OfficerRye, NY
Emma ReeveDirectorNorfolk, VA
Behzad AghazadehDirectorNew York, NY
Baiteng ZhaoDirectorMORRISTOWN, NJ
Scott GiacobelloExecutive OfficerMORRISTOWN, NJ
Caley CasteleinDirectorSan Francisco, CA
Richard MarounDirectorMORRISTOWN, NJ
Bryan BallExecutive OfficerMORRISTOWN, NJ
Dave LennonDirectorMORRISTOWN, NJ
Dave LennonExecutive OfficerMORRISTOWN, NJ
David DornanExecutive OfficerMORRISTOWN, NJ
Karin HehenbergerDirectorMORRISTOWN, NJ
Anupam DalalDirectorMORRISTOWN, NJ
Brendan DelaneyExecutive OfficerPacific Palisades, CA
Loretta ItriExecutive OfficerPacific Palisades, CA
Lance ThibaultExecutive OfficerGaithersburg, MD
Paul M WeissDirectorMadison, WI
Muneer SatterDirectorCincinnati, OH
Steven M PrelackDirectorCincinnati, OH
Anupam M DalalDirectorCincinnati, OH
Joseph GardnerDirectorCincinnati, OH
Joseph GardnerExecutive OfficerCincinnati, OH

Other filings by this issuer (4)

FiledFormOfferingSold
2025-03-18D$100.0M$100.0M
2022-10-11D$72.5M$72.5M
2021-09-10D$155.0M$155.0M
2017-03-30D$41.8M$41.8M

More